The same technology that allows medical researchers to tinker with human cells is letting agricultural scientists alter crop genes. When the first wave of CRISPR studies came out, Catherine Feuillet, an expert on wheat, who was then at the French National Institute for Agricultural Research, immediately saw its potential for her own work… At Inari Agriculture, a company in Cambridge, Dr. Feuillet is overseeing efforts to use CRISPR to make breeds of soybeans and other crops that use less water and fertilizer.
RELATED POSTS
Inari Named One of TIME’s America’s Top GreenTech Companies 2026
Inari was recognized today on TIME’s list of America’s Top GreenTech Companies 2026. Presented by TIME and Statista, the leading statistics portal and industry ranking provider, the list recognizes 250…
Inari Featured in ‘Unseen Upside’ Podcast on AI in Agriculture
Inari Chief Scientific Officer Catherine Feuillet and Lucas Mann of Inari investor Acre Venture Partners are featured in the latest episode of the Unseen Upside podcast, spotlighting our AI-enabled SEEDesign™…
Inari Repeats as AgTech Company of the Year
For the fourth time in as many years, AgTech Breakthrough has named Inari the Overall AgTech Company of the Year. The AgTech Breakthrough program strives to honor and represent the…


